戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 al epithelial cells (IEC) during colitis and colitis-associated cancer.
2  factor for colorectal cancer, also known as colitis-associated cancer.
3 imed to establish the miRNAs associated with colitis-associated cancer.
4 e (AOM) and dextran sulfate sodium to induce colitis-associated cancer.
5 lates certain proapoptotic RNAs to attenuate colitis-associated cancer.
6 ride (LPS), is over-expressed in humans with colitis-associated cancer.
7 on that may predispose to the development of colitis-associated cancer.
8 ntly upregulated in cohorts of patients with colitis-associated cancer.
9  strongly associated with the development of colitis-associated cancer.
10 olonic mucosa and tumors in a mouse model of colitis-associated cancer.
11 nduced colitis, and severe susceptibility to colitis-associated cancer.
12 ablished a key function for PHB in mediating colitis-associated cancer.
13 mmatory intestinal diseases, such as IBD and colitis-associated cancer.
14 seful therapeutic target in the treatment of colitis-associated cancer.
15  for tr-NK-1R in malignant transformation in colitis-associated cancer.
16 hogenesis of inflammatory bowel diseases and colitis-associated cancer.
17 ell hypothesis has not yet been validated in colitis-associated cancer.
18 es of dextran sodium sulfate (DSS) to induce colitis-associated cancer.
19 ease treatment and define novel mediators of colitis-associated cancer.
20  be useful in the prevention or treatment of colitis-associated cancer.
21 ing through TLR4 may lower the threshold for colitis-associated cancer.
22  and its absence promotes the development of colitis-associated cancer.
23 lead to new strategies to identify and treat colitis-associated cancers.
24  myeloid cells contributes to development of colitis-associated cancer and Apc(Min)-dependent intesti
25   These mice were bred with Apc(Min/+) mice; colitis-associated cancer and colitis were induced by ad
26  capacity of the test to distinguish between colitis-associated cancer and different ulcerative colit
27 hes to manipulate IDO1 activity in mice with colitis-associated cancer and human colon cancer cell li
28 dence for their roles in the pathogenesis of colitis-associated cancer and sporadic colorectal cancer
29  important insights into the pathogenesis of colitis-associated cancer and suggest that epidermal gro
30  of colorectal cancer gave rise to the term "colitis-associated cancer" and the concept that inflamma
31  arthritis, inflammatory intestinal disease, colitis-associated cancer, and lipopolysaccharide (LPS,
32 lammatory signature' genes characteristic of colitis-associated cancer are also upregulated in colore
33 linked to pre-existing inflammation known as colitis-associated cancer, but most develops in patients
34   Here we established a novel mouse model of colitis-associated cancer by genetically inactivating si
35 vation appears to promote the development of colitis-associated cancer by mechanisms including enhanc
36 r findings suggest that PHB protects against colitis-associated cancer by modulating p53- and STAT3-m
37 e intestine, where it helps protects against colitis-associated cancer by regulating HMOX-1 expressio
38 K1) links chronic intestinal inflammation to colitis-associated cancer (CAC) and both are exacerbated
39  myeloid AC protects from tumor incidence in colitis-associated cancer (CAC) and inhibits the expansi
40              Using an autochthonous model of colitis-associated cancer (CAC) and sporadic cancer, we
41  modulates inflammatory signals and promotes colitis-associated cancer (CAC) in mice.
42                                              Colitis-associated cancer (CAC) is a complication of inf
43                                              Colitis-associated cancer (CAC) is a major complication
44 fic IKKbeta is involved in the initiation of colitis-associated cancer (CAC), as in its absence mice
45 ling pathway are associated with colitis and colitis-associated cancer (CAC), but how IL-33 modulates
46 trast, MyD88-deficient mice are sensitive to colitis-associated cancer (CAC), since selected cytokine
47            Using a well-established model of colitis-associated cancer (CAC), we found that mice gene
48 nd proliferation of tumor cells in mice with colitis-associated cancer (CAC).
49     Here, we investigated the role of SPL in colitis-associated cancer (CAC).
50 microenvironment plays a significant role in colitis-associated cancer (CAC).
51  intestinal inflammation (i.e., colitis) and colitis-associated cancer (CAC).
52 ease increases the risks of colon cancer and colitis-associated cancer (CAC).
53 f intestinal homeostasis, leading to IBD and colitis-associated cancer (CAC).
54 xymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC).
55 rses crypt architectural changes and reduces colitis-associated cancer (CAC).
56                     PURPOSE OF REVIEW: Human colitis-associated cancers (CAC) represent a heterogeneo
57 miR-375 was significantly upregulated in the colitis-associated cancer cohort (p=0.0061) compared wit
58 mmation and contributes to the prevention of colitis-associated cancer during chronic inflammation th
59             Molecular mechanisms specific to colitis-associated cancers have been poorly characterize
60 antly attenuated intestinal inflammation and colitis-associated cancer in dextran sodium sulfate mode
61 mation increases the risk for development of colitis-associated cancer in IBD patients.
62              Conversely, in a mouse model of colitis-associated cancer, in which mice are exposed to
63                            In contrast, in a colitis-associated cancer model combining azoxymethane a
64                 SAMe or MTA treatment in the colitis-associated cancer model lowered total beta-caten
65                                      Using a colitis-associated cancer model, we show that although d
66 idence of tumors compared with controls in a colitis-associated cancer model.
67 sis, we used Nlrp1b(-/-) mice in colitis and colitis-associated cancer models.
68 s (ulcerative colitis, n=37; dysplasia, n=2; colitis-associated cancer, n=6).
69    MCC levels in IEC increase in colitis and colitis-associated cancer patients.
70 ression of beta-catenin target genes in CUC, colitis-associated cancer, tubular adenomas, and sporadi
71 dministration of dextran sodium sulfate, and colitis-associated cancer was induced by administration
72                    Using two mouse models of colitis-associated cancer, we found that epidermal growt

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。